0001225208-13-011895.txt : 20130509
0001225208-13-011895.hdr.sgml : 20130509
20130509190514
ACCESSION NUMBER: 0001225208-13-011895
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130507
FILED AS OF DATE: 20130509
DATE AS OF CHANGE: 20130509
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Abate Thomas M
CENTRAL INDEX KEY: 0001346974
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15525
FILM NUMBER: 13830628
MAIL ADDRESS:
STREET 1: C/O EDWARDS LIFESCIENCES CORPORATION
STREET 2: ONE EDWARDS WAY
CITY: IRVINE
STATE: CA
ZIP: 92614
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Edwards Lifesciences Corp
CENTRAL INDEX KEY: 0001099800
STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
IRS NUMBER: 364316614
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE EDWARDS WAY
CITY: IRVINE
STATE: CA
ZIP: 92614
BUSINESS PHONE: 9492502500
MAIL ADDRESS:
STREET 1: ONE EDWARDS WAY
CITY: IRVINE
STATE: CA
ZIP: 92614
FORMER COMPANY:
FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP.
DATE OF NAME CHANGE: 20090225
FORMER COMPANY:
FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP
DATE OF NAME CHANGE: 20000203
FORMER COMPANY:
FORMER CONFORMED NAME: CVG CONTROLLED INC
DATE OF NAME CHANGE: 19991126
4
1
doc4.xml
X0306
4
2013-05-07
0001099800
Edwards Lifesciences Corp
EW
0001346974
Abate Thomas M
ONE EDWARDS WAY
IRVINE
CA
92614
1
CVP, CFO
Common Stock
2013-05-07
4
M
0
15000.0000
21.9550
A
61689.0000
D
Common Stock
2013-05-07
4
F
0
2296.0000
63.6600
D
59393.0000
D
Common Stock
2013-05-07
4
S
0
15000.0000
63.7500
D
44393.0000
D
Employee Stock Option (Right to Acquire)
21.9550
2013-05-07
4
M
0
15000.0000
0.0000
D
2007-05-11
2013-05-10
Common Stock
15000.0000
0.0000
D
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 28, 2012.
This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.
This transaction was executed in multiple trades at prices ranging from $63.22 to $64.01. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
/s/ Denise E. Botticelli, Attorney-in-Fact
2013-05-08